Home/Pipeline/Sponsor-funded Clinical Trials

Sponsor-funded Clinical Trials

Various (e.g., Obesity, Renal/Hepatic Impairment, CNS Disorders)

Phase 1-3Active

Key Facts

Indication
Various (e.g., Obesity, Renal/Hepatic Impairment, CNS Disorders)
Phase
Phase 1-3
Status
Active
Company

About Midwest Clinical Research

Ohio Clinical Trials (OCT) is a well-established, privately-held clinical research site and service provider with nearly three decades of operational history. It possesses a significant competitive advantage through its owned 12,000 sq ft, 60+ bed inpatient facility in Columbus, Ohio, enabling complex early-phase trials including first-in-human, hepatic/renal impairment, and human abuse liability studies. As part of the ERG portfolio network, OCT leverages deep therapeutic expertise across multiple areas and a proprietary patient engagement app (MyTrial) to deliver efficient, high-quality trial execution for its biopharma clients. The company is firmly in a revenue-generating services business model, dependent on the flow of sponsored clinical trial contracts.

View full company profile